Tag: BioMed X Institute

The research of BioMed X team EPD - Early Intervention in Psychiatric Diseases - has shed light on the molecular...

A new research team at XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models...

The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who can...

Researchers at the BioMed X Institute and the Universit?tsmedizin Mannheim just published the results of their collaboration around a new...

German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer...

A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune...

BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in...

Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development

BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research:...

After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore...